SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
Over last decade, a substantial progress has been made, with respect to understanding of cancer biology and its interplay with the host immune system. Different immunotherapeutic drugs based on recombinant cytokines and monoclonal antibodies are widely used in cancer therapy, and a large number of e...
Enregistré dans:
Auteurs principaux: | T. S. Nepomnyashchikh, D. V. Antonets, R. A. Maksyutov |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2b2e74cb209d4fa0b24f5f2f85dca31b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Obtainingvaccinia virus with increased production of extracellular enveloped virions and directing GM-CSF synthesis as a promising basis for development of antitumor drug
par: T. V. Bauer, et autres
Publié: (2020) -
Viruses as nanomedicine for cancer
par: Badrinath N, et autres
Publié: (2016) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
par: Kyle M. Pierce, et autres
Publié: (2021) -
SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
par: T. S. Nepomnyashchikh, et autres
Publié: (2019) -
Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
par: Alireza Rajabzadeh, et autres
Publié: (2021)